Skip to main content

Digital Diagnostics

By Emily Olsen | 11:26 am | April 27, 2023
Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.
By Jessica Hagen | 02:43 pm | October 17, 2022
The company will use the funds to expand its platform and accelerate global commercialization.
By Emily Olsen | 12:27 pm | August 23, 2022
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
By Adam Ang | 03:36 am | June 18, 2021
Also, a study using autonomous AI to tackle diabetic eye disease will be launched in Bangladesh.
By Laura Lovett | 03:30 pm | August 21, 2020
Digital Diagnostics, formerly IDx, is looking to expand into the skin health space with this new purchase.